Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Paxot Oy
OY
Active
Y-tunnus 1991559-3
Jukolankatu 18, 80160
Joensuu
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2005
— employees
www.paxot.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Paxot Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
202
317
196
142
110
Staff expenses
−38
−44
−58
−20
−0
EBITDA
30
91
−25
18
−23
Depreciation & amort.
−2
−1
−2
−1
−1
EBIT
28
90
−27
17
−24
Net financials
−0
0
4
0
1
Profit before tax
28
90
−23
17
−23
Tax
6
18
−0
−0
−0
Net profit
22
72
−23
17
−23
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
199
261
222
210
82
Equity
186
243
202
203
20
Long-term debt
—
—
0
0
0
Short-term debt
14
18
20
7
62
Total debt
14
18
20
7
62
Financial ratios
5-year trend
EBITDA margin
-21.0%
This company
15.8%
Market median
-233% vs market
2021
2025
Equity ratio
24.4%
This company
38.2%
Market median
-36% vs market
2021
2025
Return on equity
-115.9%
This company
18.4%
Market median
-730% vs market
2021
2025
Net profit margin
-21.0%
This company
8.1%
Market median
-359% vs market
2021
2025
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
2021
2025
Debt / equity
3.10×
This company
0.62×
Market median
-400% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Paxot Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network